102 related articles for article (PubMed ID: 11410785)
1. No mutations of the Bub1 gene in human gastric carcinomas.
Shigeishi H; Yokozaki H; Kuniyasu H; Nakagawa H; Ishikawa T; Tahara E; Yasui W
Oncol Rep; 2001; 8(4):791-4. PubMed ID: 11410785
[TBL] [Abstract][Full Text] [Related]
2. No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
Nakagawa H; Yokozaki H; Oue N; Sugiyama M; Ishikawa T; Tahara E; Yasui W
Oncol Rep; 2002; 9(6):1229-32. PubMed ID: 12375025
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
4. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
[TBL] [Abstract][Full Text] [Related]
5. Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability.
Grabsch HI; Askham JM; Morrison EE; Pomjanski N; Lickvers K; Parsons WJ; Boecking A; Gabbert HE; Mueller W
J Pathol; 2004 Feb; 202(2):208-14. PubMed ID: 14743503
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma.
Nakatsuru S; Yanagisawa A; Ichii S; Tahara E; Kato Y; Nakamura Y; Horii A
Hum Mol Genet; 1992 Nov; 1(8):559-63. PubMed ID: 1338691
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
8. Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas.
Shigeishi H; Oue N; Kuniyasu H; Wakikawa A; Yokozaki H; Ishikawa T; Yasui W
Pathobiology; 2001; 69(1):24-9. PubMed ID: 11641614
[TBL] [Abstract][Full Text] [Related]
9. Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer.
Jaffrey RG; Pritchard SC; Clark C; Murray GI; Cassidy J; Kerr KM; Nicolson MC; McLeod HL
Cancer Res; 2000 Aug; 60(16):4349-52. PubMed ID: 10969775
[TBL] [Abstract][Full Text] [Related]
10. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.
Tanaka K; Nishioka J; Kato K; Nakamura A; Mouri T; Miki C; Kusunoki M; Nobori T
Jpn J Cancer Res; 2001 Sep; 92(9):952-8. PubMed ID: 11572763
[TBL] [Abstract][Full Text] [Related]
11. Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers.
Imai Y; Shiratori Y; Kato N; Inoue T; Omata M
Jpn J Cancer Res; 1999 Aug; 90(8):837-40. PubMed ID: 10543255
[TBL] [Abstract][Full Text] [Related]
12. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
Mimori K; Inoue H; Alder H; Ueo H; Tanaka Y; Mori M
Oncol Rep; 2001; 8(1):39-42. PubMed ID: 11115566
[TBL] [Abstract][Full Text] [Related]
14. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas.
Sentani K; Oue N; Kondo H; Kuraoka K; Motoshita J; Ito R; Yokozaki H; Yasui W
Pathobiology; 2001; 69(6):315-20. PubMed ID: 12324708
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas.
Jang YJ; Kim YS; Kim WH
Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274
[TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
17. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
Kasper HU; Schneider-Stock R; Mellin W; Roessner A
Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1.
Ouyang B; Knauf JA; Ain K; Nacev B; Fagin JA
Clin Endocrinol (Oxf); 2002 Mar; 56(3):341-50. PubMed ID: 11940046
[TBL] [Abstract][Full Text] [Related]
19. BUB1 infrequently mutated in human breast carcinomas.
Langerød A; Strømberg M; Chin K; Kristensen VN; Børresen-Dale AL
Hum Mutat; 2003 Nov; 22(5):420. PubMed ID: 14517964
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of caspase-2 gene in gastric and colorectal cancers.
Kim MS; Kim HS; Jeong EG; Soung YH; Yoo NJ; Lee SH
Pathol Res Pract; 2011 Oct; 207(10):640-4. PubMed ID: 21940110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
